Transaktionen anzeigen
Gesundheitswesen

Alcidion has raised capital

Alcidion Group Ltd. (ASX:ALC) has raised capital via an institutional placement. The placement was well supported by existing shareholders whilst also welcoming several new institutional shareholders to the register. Proceeds from the raise will provide Alcidion with maximum flexibility and ensure a strong balance sheet to execute on its market opportunities and enable the firm to continue to drive revenue growth.

Alcidion is a market leading healthcare software informatics company providing an innovative technology platform to improve the efficiency and quality of patient care. Its flagship platform, Miya Precision, can be deployed in a modular approach to accommodate varying customer priorities and budget profiles across the UK, Australia and New Zealand markets.

At the end of September 2023, Alcidion had A$35.3 million (US$23m) of contracted revenue for FY24 (expected to grow over the remainder of the year) and is forecasting to be EBITDA and cashflow positive.

Oaklins’ team in Australia acted as lead manager in this transaction.

PARTEIEN

Sprechen Sie mit dem Deal Team

Justin Lewis

Managing Director
Melbourne, Australien
Oaklins Henslow

Sebastian Bell

Director
Sydney, Australien
Oaklins Henslow

Transaktionen

Backspin has completed a mandatory public tender offer for the shares of Spindox
Private Equity | TMT

Backspin has completed a mandatory public tender offer for the shares of Spindox

Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.

Mehr erfahren
Rare Patient Voice has been acquired by Konovo
Gesundheitswesen | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Mehr erfahren
Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Gesundheitswesen

Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland

Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.

Mehr erfahren